Promoting freedom, innovation, and growth

Connect with IPI

Receive news, research, and updates

IPI Ideas

Publication Type 

July 15, 2004

Riding on the Coattails of U.S. Patients


Dr. Mark McClellan, former commissioner of the FDA, has claimed that other countries are not paying their fair share of pharmaceutical R&D costs. A look at the data shows that Dr. McClellan was right. Most OECD countries pay significantly less for drugs than do U.S. consumers, even when accounting for the difference in purchasing power. If other countries want to reinvigorate their pharmaceutical R&D sectors, they have to be willing to relax their price controls and let markets work.
March 22, 2004

Time to Deregulate Wireline Communications


If ever a market or an industry has undergone a revolution in ten years time, it is telecommunications. If ever a legislature should consider dramatically deregulating an industry, this is the time in telecommuncations. As the states have opportunity to revisit the missions of their respective Public Utility Commissions, they should seriously consider restricting the ability of the Commissions to regulate telecommunications.
March 1, 2004

Return of the Cybertax: Lamar Alexander's Anti-Federalism


Thanks to Sen. Lamar Alexander and a group of former Governors in the Senate, the states now have power to tax your access to the Internet. Sen. Alexander’s blocking move prevented the Senate from extending the Internet Tax Moratorium that has been standard public policy under both the Clinton and Bush administrations.

By asserting state primacy over telecommunications policy and e-commerce, Alexander and his allies are substituting their own twisted constitutional construction for the wisdom of the Founders.
September 5, 2003

Old Wine in New Wineskins--Tax Seduction in Alabama


A conservative, Republican governor in Alabama is championing a massive new tax-and-spend scheme, replete with class warfare rhetoric and hidden taxes. This represents a complete departure from the tax cuts and fiscal discipline that have been a hallmark of conservative philosophy and Republican aspirations for decades.

July 9, 2003

Parallel Importation as a Perversion of Free Trade


In the debate of legalizing the reimportation of prescription drugs into the U.S., some advocates claim that reimportation is a free trade issue, and that attempts to prevent reimportation are barriers against free trade. But manufacturers of such goods must preserve their ability to price discriminate, according to Dr. Richard Epstein. Price discrimination allows the "low demanders" to participate in the market. The result of large scale reimportation would be to restrict needed sales of drugs overseas, and would sap the incentive to innovate new products. Imposing statutory restrictions on reimportation is an effective substitute for a valid, if ineffective, contractual restraint on alienation that makes sense in light of the basic domestic decision to grant the full patent monopoly.
June 30, 2003

Five Reasons to Oppose Reimportation


The issue is safety. Twice the Secretaries of Health and Human Services have been unable to determine that U.S. consumers would be safe with large-scale prescription drug reimportation. Reasons for opposing prescription drug reimportation include: 1) U.S. Government agencies recognize the danger of illegal imports, 2) drug counterfeiting is rampant outside the U.S., 3) Canada isn't safe either, 4) it's all authorities can do to monitor the safety of drugs within the U.S., much less worrying about drugs from overseas, and 5) trial lawyers will sue pharmaceutical manufacturers for not ensuring the safety of their products, even when they have no control over them.
June 30, 2003

Reimportation: Trojan Horse, not Free Trade


Proponents claim that legalizing prescription drug reimportation from overseas countries will lower the cost of drugs to U.S. consumers, and some proponents claim that allowing reimportation is a "free trade" issue. But reimportation is a Trojan Horse for importing the deficient regulatory regimes of foreign countries, rather than importing their prices.

June 10, 2003

Equity Towards Excellence: A Proposed Framework for Funding Public Education in Texas


Texas has an education problem, not just an education-funding problem. The current “Robin Hood” school finance system is but one fact of Texas’ education problem.

May 14, 2003

The Ethical Dilemmas of Prescription Drug Reimportation


Americans are increasingly buying U.S.-made prescription drugs from Canada and other countries and bringing (i.e., reimporting) them back to the U.S. However, reimporting these drugs is breaking U.S. law. Should drug companies continue to sell to vendors who knowingly break the law and may put patients at risk? Reimportation is creating several ethical dilemmas for prescription drug manufacturers.
March 15, 2003

Business Activity Taxes--The Next Internet Tax


Driven by an insatiable appetite for tax revenue, states are attempting to impose “business activity taxes” on businesses that have no clearly-defined presence within the state. A clear, legal definition of nexus is needed so that businesses can understand when and where they can expect to be taxed. Such a definition is a legitimate role for the federal government in facilitating interstate commerce, and not a violation of federalism.

 

Total Records: 77

 

 

  • TaxBytes-New

Copyright Institute for Policy Innovation 2017. All Rights Reserved Privacy Policy Contact IPI.

e-resources e-resources